Literature DB >> 11773639

Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance.

Ralph Marvin Steinman1, Michel C Nussenzweig.   

Abstract

The immune system generally avoids horror autotoxicus or autoimmunity, an attack against the body's own constituents. This avoidance requires that self-reactive T cells be actively silenced or tolerized. We propose that dendritic cells (DCs) play a critical role in establishing tolerance, especially in the periphery, after functioning T cells have been produced in the thymus. In the steady state, meaning in the absence of acute infection and inflammation, DCs are in an immature state and not fully differentiated to carry out their known roles as inducers of immunity. Nevertheless, immature DCs continuously circulate through tissues and into lymphoid organs, capturing self antigens as well as innocuous environmental proteins. Recent experiments have provided direct evidence that antigen-loaded immature DCs silence T cells either by deleting them or by expanding regulatory T cells. This capacity of DCs to induce peripheral tolerance can work in two opposing ways in the context of infection. In acute infection, a beneficial effect should occur. The immune system would overcome the risk of developing autoimmunity and chronic inflammation if, before infection, tolerance were induced to innocuous environmental proteins as well as self antigens captured from dying infected cells. For chronic or persistent pathogens, a second but dire potential could take place. Continuous presentation of a pathogen by immature DCs, HIV-1 for example, may lead to tolerance and active evasion of protective immunity. The function of DCs in defining immunologic self provides a new focus for the study of autoimmunity and chronic immune-based diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11773639      PMCID: PMC117564          DOI: 10.1073/pnas.231606698

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  178 in total

Review 1.  The role of chemokines in the regulation of dendritic cell trafficking.

Authors:  S Sozzani; P Allavena; A Vecchi; A Mantovani
Journal:  J Leukoc Biol       Date:  1999-07       Impact factor: 4.962

Review 2.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

3.  Dendritic cells: On the move from bench to bedside.

Authors:  F O Nestle; J Banchereau; D Hart
Journal:  Nat Med       Date:  2001-07       Impact factor: 53.440

4.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

5.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.

Authors:  O Akbari; R H DeKruyff; D T Umetsu
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

6.  Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.

Authors:  P S Ohashi; S Oehen; K Buerki; H Pircher; C T Ohashi; B Odermatt; B Malissen; R M Zinkernagel; H Hengartner
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

7.  CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells.

Authors:  A J Adler; D W Marsh; G S Yochum; J L Guzzo; A Nigam; W G Nelson; D M Pardoll
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

8.  CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells.

Authors:  D R Greaves; W Wang; D J Dairaghi; M C Dieu; B Saint-Vis; K Franz-Bacon; D Rossi; C Caux; T McClanahan; S Gordon; A Zlotnik; T J Schall
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

9.  Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.

Authors:  H Groux; M Bigler; J E de Vries; M G Roncarolo
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

10.  Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells.

Authors:  F Berard; P Blanco; J Davoust; E M Neidhart-Berard; M Nouri-Shirazi; N Taquet; D Rimoldi; J C Cerottini; J Banchereau; A K Palucka
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

View more
  313 in total

1.  Immunoglobulin heavy chain constant regions regulate immunity and tolerance to idiotypes of antibody variable regions.

Authors:  Solveig Klaebo Reitan; Kristian Hannestad
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 2.  Dendritic cells and aging: consequences for autoimmunity.

Authors:  Anshu Agrawal; Aishwarya Sridharan; Sangeetha Prakash; Harsh Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2012-01       Impact factor: 4.473

3.  Ballistic CTLA4 and IL-4 gene transfer into the lower lid prolongs orthotopic corneal graft survival in mice.

Authors:  Er-Ping Zhang; Jürgen Franke; Matthias Schroff; Claas Junghans; Burghardt Wittig; Friedrich Hoffmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-10-18       Impact factor: 3.117

Review 4.  Exploiting dendritic cells to improve vaccine efficacy.

Authors:  Ralph M Steinman; Melissa Pope
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

Review 5.  Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity.

Authors:  Francesca Granucci; Ivan Zanoni; Sonia Feau; Paola Ricciardi-Castagnoli
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

Review 6.  The oral component of Sjögren's syndrome: pass the scalpel and check the water.

Authors:  Ava J Wu
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

7.  Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function.

Authors:  Donald Cheatem; Balaji B Ganesh; Eryn Gangi; Chenthamarakshan Vasu; Bellur S Prabhakar
Journal:  Clin Immunol       Date:  2009-01-25       Impact factor: 3.969

8.  Influenza virus and poly(I:C) inhibit MHC class I-restricted presentation of cell-associated antigens derived from infected dead cells captured by human dendritic cells.

Authors:  Davor Frleta; Chun I Yu; Eynav Klechevsky; Anne-Laure Flamar; Gerard Zurawski; Jacques Banchereau; A Karolina Palucka
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

9.  Amplification of autoimmune response through induction of dendritic cell maturation in inflamed tissues.

Authors:  Kristin Melli; Rachel S Friedman; Ashley E Martin; Erik B Finger; Gang Miao; Gregory L Szot; Matthew F Krummel; Qizhi Tang
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Lentivirus-delivered stable gene silencing by RNAi in primary cells.

Authors:  Sheila A Stewart; Derek M Dykxhoorn; Deborah Palliser; Hana Mizuno; Evan Y Yu; Dong Sung An; David M Sabatini; Irvin S Y Chen; William C Hahn; Phillip A Sharp; Robert A Weinberg; Carl D Novina
Journal:  RNA       Date:  2003-04       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.